Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BEPOTASTINE Cause Hepatic function abnormal? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hepatic function abnormal have been filed in association with BEPOTASTINE (Bepreve). This represents 6.9% of all adverse event reports for BEPOTASTINE.

6
Reports of Hepatic function abnormal with BEPOTASTINE
6.9%
of all BEPOTASTINE reports
2
Deaths
3
Hospitalizations

How Dangerous Is Hepatic function abnormal From BEPOTASTINE?

Of the 6 reports, 2 (33.3%) resulted in death, 3 (50.0%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BEPOTASTINE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does BEPOTASTINE Cause?

Asthma (7) Off label use (7) Cough (6) Dyspnoea (6) Nausea (6) Therapeutic product effect incomplete (6) Chronic sinusitis (5) Dyspnoea at rest (5) Dyspnoea exertional (5) Gallbladder disorder (5)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Related Pages

BEPOTASTINE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal BEPOTASTINE Demographics